Overview

Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.

Full Product Details

Author:   Michael S Ritsner
Publisher:   Springer
Imprint:   Springer
Edition:   2013 ed.
Dimensions:   Width: 15.50cm , Height: 2.30cm , Length: 23.50cm
Weight:   6.414kg
ISBN:  

9789400758049

ISBN 10:   9400758049
Pages:   287
Publication Date:   28 February 2013
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

"1. Multiple medication use in psychiatry: How Rational Can It Be?. - 2. Receptor binding targets for antipsychotic efficacy. - 3. Drug interactions and polypharmacy. - 4. Preclinical and clinical investigation of antipsychotic polypharmacy: What is the evidence?. - 5. Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy?. - 6. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt. - 7. Antipsychotic treatment within a naturalistic trial - how are we treating schizophrenia patients in the ""real-world""?. - 8. A multi-target drug treatment in schizophrenia using adjunctive agents with non-D2 mechanisms of action. - 9. Antidepressants in schizophrenia – a place for them?. - 10.  Stressful life events and anticonvulsant medication in psychiatric patients. - 11.  Multiple medication use in somatic symptom disorders: from augmentation to diminution strategies."

Reviews

From the reviews: This is part of a two-volume set that is the first comprehensive, clinically oriented reference that looks at the evidence regarding the use of multiple medications in the treatment of a variety of mental illnesses. ... should be read by anyone involved in the pharmacological management of psychiatric illnesses. (Michael Easton, Doody's Book Reviews, July, 2013)

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions